I’ve moved… Philip Fowler, 14th March 20165th August 2018 Today is my first day as a Senior Researcher in Modernising Medical Microbiology in the Nuffield Department of Medicine at the University of Oxford. Practically I’ll be based at the John Radcliffe Hospital in Oxford. I was a Postdoctoral Researcher in the SBCB Unit at the Department of Biochemistry for ten years, working with Professor Mark Sansom. During that time I used computer simulation to study the function of a variety of membrane proteins, focussing mainly on cell signalling, transporters and ion channels. Now I will be leading efforts to predict whether novel bacterial mutations lead to antibiotic resistance (or not). The key idea is to examine the effect of each mutation on the binding of the antibiotic to its target protein. This boils down to calculating how the binding free energy changes when you make the mutation — something that alchemical free energy methods, such as thermodynamic integration is well-suited to. More soon. Share this:TwitterBlueskyEmailLinkedInMastodon Related antimicrobial resistance clinical microbiology miscellaneous tuberculosis
Updated preprint: A validated cloud-based genomic platform for co-ordinated, expedient global analysis of SARS-CoV-2 genomic epidemiology 23rd January 202528th January 2025 In August 2022 seven laboratories across the world uploaded their SARS-CoV-2 genetics files for processing… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
antimicrobial resistance Can medical microbiology become a big data science? Lessons from CRyPTIC 11th March 202511th March 2025 The CRyPTIC project ran from 2017 to around 2022 and in that time collected over… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
citizen science Automated detection of bacterial growth on 96-well plates (AMyGDA) 11th December 20175th August 2018 I am involved in an international collaboration, the Comprehensive Resistance Prediction for Tuberculosis: an International Consortium… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
Congratulations, Phil! Cool to use statistical physics, computer simulations and structural biology to combat the pressing problem of bacterial resistance to antimicrobials. That’s a fight we (as a civilization) can’t afford to loose. Reply